The global energy as a service (EaaS) market is witnessing significant growth propelled by industrialization, government support, and the increasing adoption of distributed energy resources.

The global management consulting services market size will grow from $976.3 billion in 2022 to $1,022.2 billion in 2023 at a compound annual growth rate (CAGR) of more than 4%, according to The Business Research Company’s Management Consulting Services Global Market Report 2023.

The cell therapy technologies market size is expected to grow from $3.53 billion in 2022 to $4.24 billion in 2023 at a compound annual growth rate (CAGR) of 20%, according to The Business Research Company’s report Cell Therapy Technologies Global Market Report 2023.

The global aircraft landing gear market is expected to grow from $13,348.5 million in 2023 to $19,538.5 million in 2027 at a compound annual growth rate (CAGR) of 10.4%, according to a new report from The Business Research Company titled The Aircraft Landing Gear Global Market Report 2023.

The global genetic testing market is expected to grow from nearly $17.5 billion in 2023 to over $25 billion by 2027 at a compound annual growth rate (CAGR) of above 10%, as per The Business Research Company’s Genetic Testing Global Market Report 2022.

As per The Business Research Company’s dispensing pharmacy packaging machine market report, the market is expected to grow from $2.00 billion in 2023 to $2.52 billion in 2026 at a compound annual growth rate (CAGR) of 7.9%. North America is expected to be the largest region in the market during the forecast period.

Healthcare facilities are increasingly adopting healthcare predictive analytics, mainly in areas such as clinical trials, administration, and operations management, in order to provide the best care possible.

The carbon footprint management market is expected to expand significantly in the forecast period from 2022 to 2026.

The active pharmaceutical ingredients (API) manufacturing market is poised to achieve significant growth amid rapid technological advancements in the next few years, according to expert forecasts published in a new report by The Business Research Company.

The increase in development of biologics (drugs made from living organisms) is driving the adoption of biosimilars, which is a cheaper alternative with the same efficacy when compared to biologics.